GLPBio

c-RET

Read More about this category

The c-RET proto-oncogene, which was originally identified as a transforming gene by transfection of T-cell lymphoma DNA into NIH3T3 cells, is a member of the receptor tyrosine kinase (RTK) gene superfamily that encodes a receptor tyrosine kinase involved in the regulation of glial cell line-derived neurotrophic factor (GDNF) signaling. Signaling proteins, such as Grb7/Grb10, PLCγ, Shc/Enigma and Grb2, are recruited by activated c-RET protein through binding to the phosphorylated tyrosine residues in c-RET protein’s COOH-terminal sequence, Y905, Y1015, Y1062 and Y1096 respectively.  Moreover, results of in vivo studies suggest mutations of c-RET have been implicated in tumorigenesis, in which c-RET mRNA and/or protein have been found in tumors of neuroectodermal origin as well as in human neuroblastoma cell lines.

Products Related to c-RET(8)

  • GC10035 structure
    GC10035TG101209
    CAS: 936091-14-4
    Purity: >99.50%

    An inhibitor of JAK2, FLT3, RET, and JAK3

  • GC13194 structure
    GC13194RPI-1
    CAS: 269730-03-2
    Purity: >98.50%

    RPI-1은 경구로 사용할 수 있는 특정 2-인돌리논 Ret 티로신 키나제 억제제입니다. RPI-1은 인간 수질 갑상선 암종 TT 세포에서 증식, Ret 티로신 인산화, Ret 단백질 발현 및 PLC감마, ERK 및 AKT의 활성화를 억제합니다. 항종양 활성.

  • GC14534 structure
    GC14534Regorafenib monohydrate
    CAS: 1019206-88-2
    Purity: >99.50%

    A multi-kinase inhibitor

  • GC14606 structure
    GC14606Regorafenib hydrochloride
    CAS: 835621-07-3
    Purity: >99.50%

    A multi-kinase inhibitor

  • GC15217 structure
    GC15217Danusertib (PHA-739358)
    CAS: 827318-97-8
    Purity: >98.50%

    A pan-Aurora kinase and Abl inhibitor

  • GC15307 structure
    GC15307SU5416
    CAS: 204005-46-9
    Purity: >98.00%

    SU5416은 Flk-1 수용체의 자가인산화를 억제하는 소분자 Flk-1/KDR 억제제로 IC50 값은 1.23μM이다.

  • GC16362 structure
    GC16362AD57 (hydrochloride)
    CAS: 2320261-72-9
    Purity: >98%

    polypharmacological cancer therapeutic that inhibits RET.

  • GC16391 structure
    GC16391Amuvatinib (MP-470, HPK 56)
    CAS: 850879-09-3
    Purity: >98.00%

    A multi-targeted RTK inhibitor